Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016

被引:16
|
作者
Dayoub, Elias J. [1 ,2 ,3 ]
Nathan, Ashwin S. [2 ,3 ,4 ]
Khatana, Sameed Ahmed M. [2 ,3 ,4 ]
Seigerman, Matthew [4 ]
Tuteja, Sony [5 ]
Kobayashi, Taisei [1 ,2 ,4 ]
Kolansky, Daniel M. [4 ]
Groeneveld, Peter W. [1 ,2 ,3 ]
Giri, Jay [1 ,2 ,3 ,4 ]
机构
[1] Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA
[2] Univ Penn, Ctr Cardiovasc Outcomes Qual & Evaluat Res, Philadelphia, PA 19104 USA
[3] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
[4] Univ Penn, Div Cardiovasc Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
关键词
acute coronary syndrome; clopidogrel; heart diseases; percutaneous coronary intervention; ticagrelor;
D O I
10.1161/CIRCINTERVENTIONS.118.007434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Percutaneous coronary intervention for the management of stable ischemic heart disease
    Liu, Shuangbo
    Tsang, Michael
    Abdel-Qadir, Husam
    Yanagawa, Bobby
    Bagai, Akshay
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (05) : 557 - 563
  • [2] TRIPLE THERAPY WITH PRASUGREL OR TICAGRELOR COMPARED TO CLOPIDOGREL AFTER PERCUTANEOUS CORONARY INTERVENTION
    Coons, James
    Verlinden, Nathan
    Iasella, Carlo
    Saul, Melissa
    Kane-Gill, Sandra
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 196 - 196
  • [3] Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention
    Mangiacapra, Fabio
    Colaiori, Iginio
    Di Gioia, Giuseppe
    Pellicano, Mariano
    Heyse, Alex
    Paolucci, Luca
    Peace, Aaron
    Bartunek, Jozef
    de Bruyne, Bernard
    Barbato, Emanuele
    HEART, 2024, 110 (02) : 115 - 121
  • [4] The Misinterpretation of Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Ischemic Heart Disease
    Bates, Eric R.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (05) : 479 - 481
  • [5] Treating stable ischemic heart disease with percutaneous coronary intervention - The debate continues
    Puri, Rishi
    Nicholls, Stephen J.
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2012, 2 (04) : 264 - 267
  • [6] Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease
    Francisco Ujueta
    Ephraim N. Weiss
    Binita Shah
    Steven P. Sedlis
    Current Cardiology Reports, 2017, 19
  • [7] Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease
    Ujueta, Francisco
    Weiss, Ephraim N.
    Shah, Binita
    Sedlis, Steven P.
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (02)
  • [8] The role of percutaneous coronary intervention in managing patients with stable ischemic heart disease
    Herbert, Tara
    Rizzolo, Denise
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2020, 33 (06): : 18 - 23
  • [9] Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention
    Sucato, Vincenzo
    Corrado, Egle
    Castellana, Carmelo
    Carella, Michele
    Raso, Simona
    Coppola, Giuseppe
    Andolina, Giuseppe
    Novo, Giuseppina
    Evola, Salvatore
    Novo, Salvatore
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 (06) : 450 - 451
  • [10] Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
    Xi, Ziwei
    Li, Jianan
    Qiu, Hong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Dou, Kefei
    Xu, Bo
    Wu, Yongjian
    Qiao, Shubin
    Yang, Weixian
    Yang, Yuejin
    Gao, Runlin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8